Bal Pharma Ltd

NSE : BALPHARMA10 Jan 2025
Pharmaceuticals
₹
+1.28 (+1.09%)
Lowest Today
Highest Today
Today’s Open
Prev. Close
52 Week High
52 Week Low
BUY
SELL
To Invest in Bal Pharma Ltd
Bal Pharma Ltd
Pharmaceuticals
NSE : BALPHARMA10 Jan 2025
₹
+1.28 (+1.09%)
OverviewFundamentals
1D
1M
6M
1Y
5Y
All

Bal Pharma Ltd - Share Price & Details

Traded Volume
₹
Market Cap(Cr)
Avg Traded Price
1 Year return
4.55%
Upper Circuit
Lower Circuit
P/E TTM
17.27
P/B Ratio
1.77
Traded Value(Cr)
0.00
EPS TTM
6.8
Book value
Dividend
1.01%

Invest in Bal Pharma Ltd at ZERO Brokerage for 30 days

Price Performance

-6.39 %
1 Wk
-1.47 %
1 M
-8.53 %
3 M
4.55 %
1 Y
-5.63 %
YTD

Traded Volume Movement

Technical Details

Support 3
112
Support 2
114
Support 1
116
Pivot Point :
118
Resistance 1
121
Resistance 2
122
Resistance 3
125

Peer Comparison

Scrip NamePriceDaily ChangeM.Cap (Cr)1 Year Returns %P/E (TTM)PB Ratio
Bal Pharma Ltd
₹118.72(+1.28/1.09%)
118.72+1.28189.014.5517.271.77
Lupin Ltd
₹2,191.10(-61.75/-2.74%)
2,191.10-61.7599,965.5555.9233.344.55
Ipca Laboratories Ltd
₹1,632.35(-29.60/-1.78%)
1,632.35-29.6041,413.4146.2459.326.14
J B Chemicals & Pharmaceuticals Ltd
₹1,823.05(-47.25/-2.53%)
1,823.05-47.2528,357.318.5347.268.98
IOL Chemicals & Pharmaceuticals Ltd
₹409.15(-14.00/-3.31%)
409.15-14.002,401.94-12.4323.981.45
Sanofi India Ltd
₹5,881.55(-78.35/-1.31%)
5,881.55-78.3513,545.21-30.7132.0619.74

About Bal Pharma Ltd

Bal Pharma Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 186.99 crores. It has reported a sales of Rs. 73.13 crores and a net profit of Rs. 1.75 crores for the quarter ended December 2018. The company management includes , Shailesh Siroya,Himesh Virupakshaya,H S Venkatesh,Nicola Neeladri,Jatish Sheth,Kotian Chittananda Damodar,Abdul Basith (Bal Pharma Ltd) among others.
Chairman
Registered office
21 & 22 Bommasandra Indl Area,Hosur Road,Bangalore,Karnataka,560092
FAX :
Background
Incorporation Year1987
Face Value₹10
Market Lot1

Latest News

Sunteck Realty sale bookings up 40% to Rs 635 crore in Q3 FY25

Sunteck Realty has reported 40 per cent growth in its sale bookings to Rs 635 crore during the latest December quarter, driven by bullish housing demand. In a regulatory filing late Friday, Sunteck Realty said the company's sale bookings or pre-sales in the year-ago period was Rs 455 crore.  During April-December period of 2024-25, the company's pre-sales registered a growth of 34%.
12 Jan 2025 | 09:58 PM

Stocks to buy under ₹100: Sumeet Bagadia recommends for tomorrow

The Indian markets witnessed a continued sell-off for the third straight trading session on Friday, January 10.
📌Lloyds Engineering Works: Momentum buy at ₹83.26, Stop Loss of ₹80; Target Price of ₹90.
📌NACL Industries: Momentum buy at ₹68.39, Stop Loss of ₹65; Target Price of ₹73.
📌Jain Irrigation Systems: Momentum buy at ₹73.93, Stop Loss of ₹71; Target Price of ₹79.
12 Jan 2025 | 09:49 PM

Ganesh Dongre of Anand Rathi recommends three stocks to buy tomorrow

Looking ahead to the January series, a sustained bullish trend will require a close above the 24,250 mark. This would pave the way for a move toward the 24,600–24,800 resistance zone.
📌Buy Hindustan Petroleum Corp at ₹388; Stop Loss at ₹375; Target of ₹410.
📌Buy HCL Tech at ₹1995; Stop Loss at ₹1940; Target Price of ₹2060.
📌Buy Tata Motors at ₹775; Stop Loss at ₹730; Target Price of ₹815.
12 Jan 2025 | 09:47 PM

S&P’s $18 Trillion Rally Threatened by Psychology of 5% Yields

For years it’s seemed like nothing could stop the stock market’s inexorable march higher, as the S&P 500 Index soared more than 50% from the start of 2023 to the end of 2024, adding $18 trillion in value in the process. Now, however, Wall Street is seeing what can ultimately derail this rally: Treasury yields above 5%.
12 Jan 2025 | 09:44 PM

Bond surge triggers retail investor frenzy

Chancellor of the Exchequer Rachel Reeves Turmoil in the bond market has prompted a surge of interest from everyday savers seeking to take advantage of higher returns. Retail investors are rushing to buy gilts – as UK Government bonds are known – after a recent surge in their yields, which are the effective interest rate offered.
12 Jan 2025 | 09:43 PM
view more news

How to buy Bal Pharma Ltd shares on nse?

To buy Bal Pharma Ltd shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Bal Pharma Ltd share price today?

The Bal Pharma Ltd shares price on nse is Rs.118.72 today.

What is the market cap of Bal Pharma Ltd shares on NSE ?

The company has a market capitalization of Rs.189.01Cr

What is the PE & PB ratio of Bal Pharma Ltd shares ?

PE is 17.27 and PB is 1.77

What is the 52 Week High and Low of Bal Pharma Ltd shares?

Bal Pharma Ltd stock price high: Rs.157.98 Bal Pharma Ltd stock price low: Rs.88.95
BUY
SELL
Click here to see your activities